Stock vs Stock Comparison

Waters Corporation vs Johnson & Johnson

JNJ wins the Tale of the Tape 5–3.

WAT$371.93
JNJ$222.89

🏆 Tale of the Tape

35
WATJNJ
20.3%Profitability (Net Margin)28.5%
48.8xValuation (P/E)26.1x
17.0%Efficiency (ROIC)18.3%
4/9Health (Piotroski F)4/9
11.7Safety (Altman Z)4.0
7.0%Growth (Rev YoY)6.0%
-0.05Risk (Sharpe 1Y)2.69
0.98xBalance Sheet (D/E)1.44x
1.70%FCF Yield3.25%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.199
252-Day Correlation
0.080
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricWATJNJ
Market Cap$37.7B$542.4B
P/E Ratio48.8x26.1x
Forward P/E23.4x17.7x
P/B8.92x6.68x
Dividend Yield2.38%
Beta1.140.26

Quantitative Metrics

MetricWATJNJ
DCF Fair Value$48.56$134.24
DCF Upside-85.0%-43.6%
Piotroski F4/94/9
Altman Z11.743.97
Beneish M-2.38-2.27
FCF Yield1.70%3.25%
Net Debt/EBITDA0.3x0.5x
ROIC17.0%18.3%
WACC12.0%7.7%
ROIC – WACC5.0pp10.5pp
Gross Margin59.3%67.9%
Net Margin20.3%28.5%
Rev Growth YoY7.0%6.0%
Sharpe (1Y)-0.052.69
Max Drawdown 3Y-16.0%
FCF Payout Ratio64%

WAT Price

Loading chart...

JNJ Price

Loading chart...

ETF Exposure

WAT found in:

VOT0.71%
XLV0.62%
VHT0.49%
VO0.31%
RSP0.18%
VFQY0.18%
ONEV0.13%
SCHG0.12%
SPYV0.12%
ONEO0.08%
IWD0.07%
VUG0.06%
VONV0.06%
ESGV0.06%
VTV0.06%
QUS0.06%
SPY0.05%
SCHX0.05%
VONE0.05%
VOO0.05%
SPTM0.05%
SCHB0.05%
VTI0.04%
IVV0.04%
URTH0.04%
SPLG0.03%
ITOT0.03%
IWF0.03%
VONG0.03%
ACWI0.02%

JNJ found in:

XLV10.42%
IYH10.14%
VHT8.84%
HDV6.84%
MTUM3.76%
DIA2.83%
MGV2.75%
DGRO2.64%
VIG2.49%
VYM2.30%
VTV2.16%
DGRW2.02%
SCHV2.02%
IWD1.94%
QUS1.81%
XPH1.74%
VONV1.69%
NOBL1.58%
VFMV1.42%
VFMO1.02%
SCHX0.96%
SPYG0.94%
SDY0.93%
VOO0.90%
SCHB0.90%
SPY0.87%
IVV0.85%
VONE0.84%
SPTM0.81%
VTI0.80%
SPYV0.79%
SPLG0.76%
ITOT0.75%
URTH0.70%
ACWI0.57%
VT0.49%
RSP0.21%
VFVA0.15%
ONEO0.05%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

WAT vs JNJ: Head-to-Head Analysis

Waters Corporation (WAT) and Johnson & Johnson (JNJ) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, JNJ leads 5–3 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, WAT generates a return on invested capital (ROIC) of 17.0% compared to JNJ's 18.3%. This suggests JNJ is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between WAT and JNJ is 0.199, indicating low correlation, making them an effective diversification pair in a portfolio context.

WAT appears in 30 ETFs tracked by SecuritiesDB, while JNJ appears in 39 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, WAT or JNJ?

Our quantitative analysis compares WAT and JNJ across nine fundamental dimensions. JNJ wins the Tale of the Tape 5–3. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are WAT and JNJ correlated?

The 252-day correlation between WAT and JNJ is 0.199. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.